tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robin Garner, 10 are a BUY (100%).
Analyst Robin Garner, carries an average stock price target met ratio of 66.67% that have a potential upside of 74.81% achieved within 190 days. Previously, Robin Garner worked at CRAIG HALLUM.
Robin Garner’s has documented 20 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AVDL, Avadel Pharmaceuticals PLC at 12-Jan-2024.
Analyst best performing recommendations are on LABP (LANDOS BIOPHARMA).
The best stock recommendation documented was for AVDL (AVADEL PHARMACEUTICALS PLC) at 5/27/2022. The price target of $15.5 was fulfilled within 348 days with a profit of $13 (520%) receiving and performance score of 14.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2021
$20.42
$-2.51 (-10.95%)
$500
2 years 6 months 4 days ago
(01-Apr-2024)
0/2 (0%)
$-1.18 (-5.46%)
Hold Since 06-Jan-2023
$1
$-21.93 (-95.64%)
$14
3 years 8 months 29 days ago
(06-Jan-2023)
1/4 (25%)
$-3.05 (-75.31%)
713
Hold Since 12-Aug-2022
3 years 10 months 24 days ago
(11-Nov-2022)
0/2 (0%)
$53.4 (50.09%)
Buy Since 01-Mar-2021
$9
4 years 1 months 23 days ago
(12-Aug-2022)
2/2 (100%)
$-8.7 (-49.15%)
181
Hold Since 01-Mar-2021
$70
$47.07 (205.28%)
$170
4 years 9 months 2 days ago
(03-Jan-2022)
0/2 (0%)
$17.8 (34.10%)
